Beclomethasone (Vanceril, Beconase, Vancenase, Beconase AQ, Vancenase AQ, Vancenase AQ Double Strength)

Category:

  • Anti-inflammatory corticosteroid (synthetic)

Description:

  • Halogenated synthetic glucocorticoid

Indications:

  • INH for chronic asthma

  • NASAL for seasonal/perennial rhinitis; prevention of recurrence of nasal polyps; non-allergic (vasomotor) rhinitis

Contraindications:

  • Primary treatment of status asthmaticus, nonasthmatic bronchial disease

  • Bacterial, fungal, or viral infections of the mouth, throat, or lungs; children <3 years

Precautions:

  • Pregnancy category C; excretion in breast milk unknown, but considered to be compatible with breast feeding

  • Nasal disease/surgery, children <12 years, nasal ulcers, recurrent epistaxis

  • Systemic effects such as mental disturbances, increased bruising, weight gain, cushingoid features, and cataracts

Adverse Reactions (Side Effects):

  • CNS: headache, paresthesia

  • EENT: burning, candidal infection, dryness, earache, nasal irritation, perforation at nasal septum, nasal ulcers, secretions with blood, sneezing, sore throat

  • GI: dry mouth, dysphonia

  • METAB: adrenal suppression

  • RESP: bronchospasm

 

Dosage:

Administered by oral inhalation and nasally

  • Adult:  INH 2-4 puffs 3-4 times daily, not to exceed 20 INH/day; NASAL 1-2 sprays in each nostril 2-4 times daily; double strength (DS) NASAL 1-2 sprays each nostril daily

  • Child 2-12 years: INH 1-2 puffs 3-4 times daily, not to exceed 10 INH/day

  • Child >12 years:  NASAL 1-2 sprays each nostril 2-4 times daily

 

Special Considerations:

  • Rinse mouth with water following INH to decrease possibility of fungal infections, dysphonia

  •  Response to nasal steroids seen in 3 days to 2 weeks; discontinue if no improvement in 3 weeks

  •  For prophylactic use, no role in acute treatment of asthma/allergy

 

 

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

Approved for public release; Distribution is unlimited.

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.

Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates, LLC.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

© 2015, Brookside Associates, LLC. All rights reserved

Other Brookside Products

 

 

Advertise on this site